Published in Gastroenterology on November 01, 1997
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
TIPSS 10 years on. Gut (2000) 1.48
Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol (2013) 1.05
Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03
Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol (2014) 0.89
Transjugular intrahepatic portosystemic shunt. Clin Liver Dis (2014) 0.84
Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease. Int J Hepatol (2011) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Transjugular portosystemic stent shunt in treatment of liver diseases. World J Gastroenterol (2001) 0.81
Interventional radiology in the management of portal hypertension. Indian J Radiol Imaging (2008) 0.79
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage. Gastroenterol Res Pract (2013) 0.79
Current status of transjugular intrahepatic portosystemic shunts. Postgrad Med J (1998) 0.78
Direct intrahepatic portacaval shunt: an experimental study. World J Gastroenterol (2003) 0.77
Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open (2013) 0.76
Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding. Surg Endosc (2013) 0.75
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75
Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension. Oncotarget (2016) 0.75
Octreotide followed by sclerotherapy was not more effective than emergency injection sclerotherapy for acute variceal haemorrhage. Gut (1998) 0.75
Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) (2016) 0.75
Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism. Int J Clin Exp Med (2015) 0.75
TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update. J Huazhong Univ Sci Technolog Med Sci (2017) 0.75
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (1999) 24.31
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology (2001) 2.61
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy (2006) 2.24
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther (2014) 2.15
Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol (1997) 2.09
Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy (2001) 2.07
Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science (1986) 2.00
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A (2001) 1.84
Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology (1996) 1.81
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol (1993) 1.73
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients. Gastrointest Endosc (2001) 1.63
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ (2004) 1.62
Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc (1998) 1.60
Presentation and physical evaluation of RadioVisioGraphy. Oral Surg Oral Med Oral Pathol (1989) 1.58
Improved tumor staging by diagnostic laparoscopy. Z Gastroenterol (1999) 1.58
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology (1996) 1.53
Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand (1995) 1.52
Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol (1994) 1.52
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
[Case report: massive lower intestinal bleeding from ileal varices: treatment with transjugular intrahepatic portosystemic shunt (TIPSS)]. Radiologe (2007) 1.49
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Manganese and chronic hepatic encephalopathy. Lancet (1995) 1.47
Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients. Endoscopy (2002) 1.47
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Long-term follow-up of patients with iron deficiency anemia after a close endoscopic examination of the upper and lower gastrointestinal tract. Z Gastroenterol (2000) 1.41
Efficacy of intraoral topical anesthetics in children. J Dent (2005) 1.40
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
Detection of large intrahepatic cholangiectases in patients with primary sclerosing cholangitis by endoscopic retrograde cholangiography. Endoscopy (1990) 1.38
Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol (1997) 1.35
Modelling supply and demand of bioenergy from short rotation coppice and Miscanthus in the UK. Bioresour Technol (2010) 1.35
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene (1992) 1.34
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci (1997) 1.34
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience. Endoscopy (1998) 1.30
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry. Scand J Gastroenterol (2004) 1.29
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Bile salt sulphates in cholestasis. Eur J Clin Invest (1974) 1.27
Hepatocellular influx of [14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci U S A (1986) 1.26
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology (1990) 1.25
Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene (2001) 1.24
[Prevalence of Gilbert's syndrome in Germany]. Dtsch Med Wochenschr (1987) 1.23
Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver. Gastroenterology (1975) 1.23
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia (1984) 1.23
Analysis of hepatitis C virus core protein interaction domains. J Gen Virol (1997) 1.21
Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology (1987) 1.21
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J Biol Chem (1997) 1.19
Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem (1997) 1.17
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies. Immunology (1996) 1.17
Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest (1985) 1.16
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Clin Pharmacol Ther (1983) 1.16
Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J Gastroenterol (1999) 1.16
Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem (1988) 1.15
Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull (2001) 1.14
Characterization of large surface proteins of hepatitis B virus by antibodies to preS-S encoded amino acids. Virology (1986) 1.12
Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest (1983) 1.10
Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol (2001) 1.10
Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood (1997) 1.08
Placement of balloon-expandable intraluminal stents in iliac arteries: first 171 procedures. Radiology (1990) 1.07
Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Cancer Res (1981) 1.07
[Imaging of the hip joint hyaline cartilage with MR tomography using a gradient echo sequence with fat-water phase coherence]. Rofo (1990) 1.07
Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphipathic compounds. Proc Soc Exp Biol Med (1996) 1.07
Intraluminal stents in atherosclerotic iliac artery stenosis: preliminary report of a multicenter study. Radiology (1988) 1.06
Detection of pre-S1 proteins in serum and liver of HBsAg-positive patients: a new marker for hepatitis B virus infection. Hepatology (1986) 1.06
Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J Virol (1986) 1.06
False-positive anti-HCV tests in rheumatoid arthritis. Lancet (1990) 1.06
Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera. Virology (1987) 1.05
Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut (2003) 1.05